Complete remission in Cronkhite-Canada syndrome

Area of Science:

• Gastroenterology
• Internal Medicine
• Clinical Case Reports

Background:

• Cronkhite-Canada syndrome (CCS) is a rare disorder characterized by generalized gastrointestinal polyposis, ectodermal abnormalities, and protein-losing enteropathy.
• The exact etiology of CCS remains unclear, though it is generally considered a non-neoplastic, inflammatory condition.

Observation:

• A patient presented with classic symptoms of Cronkhite-Canada syndrome, including widespread gastrointestinal polyps, hypoalbuminemia, skin pigmentation, nail dystrophy (onycho-dystrophy), and hair loss (alopecia).
• The patient's condition was confirmed through radiological, endoscopic, and histological examinations.

Findings:

• Complete remission of Cronkhite-Canada syndrome was achieved solely through 10 weeks of enteral nutrition.
• Radiological, endoscopic, and histological assessments confirmed the disappearance of gastrointestinal polyps and resolution of ectodermal manifestations within 4 months of initiating nutritional therapy.
• The case supports the hypothesis that nutritional deficiencies may play a significant role in the pathogenesis of CCS.

Implications:

• This successful treatment outcome suggests that aggressive nutritional support, specifically enteral nutrition, should be a primary consideration in managing Cronkhite-Canada syndrome.
• The findings reinforce the understanding of CCS polyps as essentially inflammatory and non-neoplastic, responding favorably to nutritional intervention.
• Further research into the role of nutritional deficiencies in CCS is warranted to optimize treatment strategies.